Programmable therapeutic platforms built on metal-ligand logic — from redox triggers to molecular coordination gates.
MDC is a patented logic-structured therapeutic platform developed by Kunfirm Technologies. It uses precision metal coordination chemistry to create targeted, responsive, and programmable therapeutic complexes. Unlike traditional compounds, MDC molecules behave based on embedded logic — activating only under specific biological conditions such as pH changes, redox states, or receptor presence.
Compounds are engineered to activate only when specific molecular conditions are met — a breakthrough in targeted therapy control.
Supports oncology, neurology, infectious disease, and more — through conditional release, metal swapping, and pathway gating.
The MDC framework is protected under multiple provisional patents, with tiered licensing rights available to qualified partners.
Moleculogic is the simulation brain of MDC. It powers our compound logic blueprints, simulates entropy-class triggers, and validates therapeutic behavior before synthesis. Every MDC blueprint passes through this logic-first environment — ensuring traceability, reproducibility, and intelligent design.
Browse our growing collection of Metal-Drug Complexes designed for various therapeutic applications. Each compound features unique properties and targeted functionality.
Start with our Tier 0 preview or request Tier 1 access to begin running your own logic-driven molecular simulations.